1Barst RJ,McGoon M,Torbicki A,Sitbon O Krowka MJ Olschewski H. Diagnosis and differential assessment of pulmonary arterial hypertension[J].Journal of the American College of Cardiology,2004,(12 Suppl):40S-47S.
2Archer SL,Weir EK,Wilkins MR. Basic science of pulmonary arterial hypertension for clinicians:new concepts and experimental therapies[J].Circulation,2010.2045-2066.
3Iwai M,Horiuchi M. Devil and angel in the renin-angiotensin system: ACE-angiotensin Ⅱ-AT1 receptor axis vs.ACE2-angiotensin-(1-7)-Mas receptor axis[J].Hypertension Research,2009.533-536.
4Shenoy V,Qi Y,Katovich MJ,Raizada MK. ACE2,a promising therapeutic target for pulmonary hypertension[J].Current Opinion in Pharmacology,2011.150-155.
5Bradford CN,Ely DR,Raizada MK. Targeting the vasoprotective axis of the renin-angiotensin system:a novel strategic approach to pulmonary hypertensive therapy[J].Current Hypertension Reports,2010.212-219.
6Hyman AL,Hao Q,Tower A,Kadowitz PJ,Champion HC,Gumusel B. Novel catheterization technique for the in vivo measurement of pulmonary vascular responses in rats[J].American Journal of Physiology,1998,(4 Pt,2):H1218-HH229.
7Nishimura T,Vaszar LT,Faul JL,Zhao G Berry GJ Shi L. Simvastatin rescues rats from fatal pulmonary hypertension by inducing apoptosis of neointimal smooth muscle cells[J].Circulation,2003,(13):1640-1645.doi:10.1161/01.CIR.0000087592.47401.37.
8Noble JE,Bailey MJ. Quantitation of protein[J].Methods in Enzymology,2009.73-95.
9Vickers C,Hales P,Kaushik V,Dick L Gavin J Tang J. Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase[J].Journal of Biological Chemistry,2002.14838-14843.doi:10.1074/jbc.M200581200.
10Oudit GY,Crackower MA,Backx PH,Penninger JM. The role of ACE2 in cardiovascular physiology[J].Trends in Cardiovascular Medicine,2003.93-101.doi:10.1016/S1050-1738(02)00233-5.
